Academic/Biomedical Research
News & Jobs

Employers
Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

News | News By Subject | News by Disease | News By Date | Search News

Cancer (misc) News Articles

Get Our Industry eNewsletter FREE

email:

Top Breaking News

Roche Banks on New Drug Data to Defend Cancer Business 5/16/2013 More...

Eli Lilly and Company to Take $30 Million Charge After Cancer Drug Fails Phase 3 Trial 5/15/2013 More...

ZIOPHARM Oncology, Inc. Cancer Drug Fails in Late-Stage Trial; Shares Plunge 3/27/2013 More...

Sun Pharmaceutical Industries Ltd Receives U.S. Nod for Cancer Drug "Doxil" 2/7/2013 More...

Genentech's Cancer-Fighting T-DM1 Leads FDA Class of 2013 1/2/2013 More...

Merck & Co., Inc., Roche and Sanofi (France) to Test Drug That Aims to Make Cancer Self-Destruct 1/1/2013 More...

AEterna Zentaris Says FDA Supports Phase 3 Trials of Cancer Treatment 1/1/2013 More...

Celgene's Pomalidomide Helps in Myeloma After Others Fail 12/12/2012 More...

Strides Arcolab Limited Inks Pact With Eli Lilly and Company for Cancer Drugs 12/5/2012 More...

Cipla Ltd. Slashes Cancer Drug Prices by Up to 64 Pct 11/8/2012 More...

Big Pharmas Such as Roche. Eli Lilly and Company Crunch the Numbers to Boost Odds Against Cancer 11/2/2012 More...

Ensemble Therapeutics Corporation, Boehringer Ingelheim Corporation Ink $186 Milliion Macrocycle Drug Pact 11/1/2012 More...

Menarini, Oxford BioTherapeutics Ink $1 Billion Cancer Pact; Partnership Will Develop Five Antibody-Based Anticancer Drugs 10/29/2012 More...

Novartis AG Cannibalizes Gleevec to Boost New Cancer Drug 10/29/2012 More...

Abbott Laboratories, Seattle Genetics, Inc. Sign Cancer Pact Worth $245 Million 10/23/2012 More...

Featured Stories

Why We Should Spend More on Pricey Cancer Drugs 6/11/2013 More...

Epigenetic Factor Likely Plays a Key Role in Fueling Most Common Childhood Cancer, St. Jude Children's Research Hospital Study 6/11/2013 More...

New Drug Helps Shrink Tumors in Rare Eye Cancer, Memorial Sloan-Kettering Cancer Center Study 6/3/2013 More...

Changing Cancer's Environment to Halt Its Spread, Boston Children's Hospital Study 5/22/2013 More...

Possible Treatment for Serious Blood Cancer, Lund University Study 5/7/2013 More...

Virginia Commonwealth University Researchers Look to Mathematics, Nature, to Understand the Immune System and Its Role in Cancer 5/2/2013 More...

Moffitt Cancer Center Researchers Design Small Molecule to Disrupt Cancer-Causing Protein 3/26/2013 More...

New Monoclonal Antibody Developed That Can Target Proteins Inside Cancer Cells, Memorial Sloan-Kettering Cancer Center and Eureka Therapeutics Study 3/14/2013 More...

Compound Stimulates Tumor-Fighting Protein in Cancer Therapy, Penn State University Study 2/7/2013 More...

Medal-Awarded Isotopes for Production of New Radiopharmaceuticals for Cancer Treatment, National Center for Nuclear Research Study 1/3/2013 More...

New Insight Into Cell Development and Cancer, University of North Carolina Study 1/1/2013 More...

Understanding Cell Organization to Tackle Cancer, University of Manchester Study 12/27/2012 More...

Pancreatic Cancer and Fat Hormone Linked, Brigham and Women's Hospital and Harvard Medical School Study 12/18/2012 More...

Broccoli Compound Kills Cancer Cells, University of Michigan Study 12/17/2012 More...

Caffeinated Coffee May Reduce the Risk of Oral Cancers, American Journal of Epidemiology Reveals 12/11/2012 More...

More News

NW Bio Has Initiated Its DCVax®-Direct Phase I/II Trial for All Solid Tumor Cancers 6/13/2013 More...

Navidea Biopharmaceuticals (NAVB) Announces Presentation of Meta-Analysis Results of Lymphoseek® and ACOSOG Radiolabeled Colloid in Head and Neck Cancer 6/12/2013 More...

Immunomedics, Inc. (IMMU) Release: 90Y-Epratuzumab Study Shows Improvement of Therapy Results Following R-CHOP 6/11/2013 More...

Champions Oncology, Inc. (CSBR) Study Results Highlighted in Presentation at American Society of Clinical Oncology 6/5/2013 More...

NeoStem, Inc.'s Subsidiary, Progenitor Cell Therapy, Enters Into a Manufacturing Agreement With ImmunoCellular Therapeutics, Ltd. for Dendritic Cell Vaccines Targeting Brain and Other Cancers 6/3/2013 More...

Curis, Inc. (CRIS) Announces CUDC-427 (GDC-0917) Phase I Clinical Data Presented at American Society of Clinical Oncology 2013 Annual Meeting 6/3/2013 More...

TetraLogic Pharmaceuticals Announces Oral Presentation of Clinical Data on Birinapant at the 2013 American Society of Clinical Oncology Annual Meeting 6/3/2013 More...

OncoMed Pharmaceuticals, Inc. Presents Phase 1 Data in Solid Tumor Patients for the First-in-Class Wnt Pathway Targeting Antibody Vantictumab (OMP-18R5) at American Society of Clinical Oncology 6/3/2013 More...

Nektar Therapeutics (CA) (NKTR) Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting 6/3/2013 More...

Threshold Pharmaceuticals, Inc. (THLD) Announces Data From Two Ongoing Phase 1/2 Trials of TH-302 at the 2013 American Society of Clinical Oncology Annual Meeting 6/3/2013 More...

Galena Biopharma (GALE) Provides Product Pipeline Update at the American Society of Clinical Oncology 2013 Annual Meeting 6/3/2013 More...

Curis, Inc. (CRIS) American Society of Clinical Oncology Presentation Highlights the Utility of Molecular Profiling for the Management of Rare and Aggressive Cancers 6/3/2013 More...

NewLink Genetics Presents Results From Two Phase 1 Studies With Immunotherapy Agent, Indoximod, at the American Society of Clinical Oncology 2013 Annual Meeting 6/3/2013 More...

CytRx Corporation (CYTR) Announces the Presentation of Favorable Results From Novel Combination of Aldoxorubicin and Doxorubicin in a Phase 1b Clinical Trial at American Society of Clinical Oncology Conference 6/3/2013 More...

Karyopharm Therapeutics to Present New Data on Selective Inhibitor of Nuclear Export (SINE), KPT-330, at 2013 European Hematology Association Congress 5/29/2013 More...